GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹255 Cr | ₹262 Cr | ₹259 Cr | ₹262 Cr | ₹2,920 Cr |
What is the latest Long Term Provisions ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹255 Cr |
Mar2022 | ₹262 Cr |
Mar2021 | ₹259 Cr |
Mar2020 | ₹262 Cr |
Mar2019 | ₹2,920 Cr |
How is Long Term Provisions of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹255 Cr | -2.83 | |
Mar2022 | ₹262 Cr | 1.05 | |
Mar2021 | ₹259 Cr | -0.86 | |
Mar2020 | ₹262 Cr | -91.04 | |
Mar2019 | ₹2,920 Cr | - |
Compare Long Term Provisions of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹38,818.9 Cr | 14.7% | 20.6% | 58.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | 0.4% | -0.4% | 61.2% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | -1.1% | 1.7% | 53.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 5.9% | 11.3% | 94.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | -0.1% | 3.9% | 20% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -2% | -4.2% | 29.3% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 14.7% |
20.6% |
58.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses